←Back to Expert Scholars
Translational Medicine / 转化医学Precision Oncology, Early Phase Trials
Funda Meric-Bernstam
MD
🏢MD Anderson Cancer Center🌐USA
Chair Investigational Cancer Therapeutics
110
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Funda Meric-Bernstam chairs investigational cancer therapeutics at MD Anderson and has led numerous precision oncology and basket trials including work in NCI-MATCH. Her molecular tumor board at MD Anderson is a global model. She has advanced HER2 targeted therapy across tumor types.
Share:
🧪Research Fields 研究领域
molecular tumor board
precision oncology
basket trials
HER2
NCI MATCH
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Funda Meric-Bernstam 的研究动态
Follow Funda Meric-Bernstam's research updates
留下邮箱，当我们发布与 Funda Meric-Bernstam（MD Anderson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment